TY - JOUR
T1 - SCMR expert consensus statement for cardiovascular magnetic resonance of patients with a cardiac implantable electronic device
AU - Kim, Daniel
AU - Collins, Jeremy D.
AU - White, James A.
AU - Hanneman, Kate
AU - Lee, Daniel C.
AU - Patel, Amit R.
AU - Hu, Peng
AU - Litt, Harold
AU - Weinsaft, Jonathan W.
AU - Davids, Rachel
AU - Mukai, Kanae
AU - Ng, Ming Yen
AU - Luetkens, Julian A.
AU - Roguin, Ariel
AU - Rochitte, Carlos E.
AU - Woodard, Pamela K.
AU - Manisty, Charlotte
AU - Zareba, Karolina M.
AU - Mont, Lluis
AU - Bogun, Frank
AU - Ennis, Daniel B.
AU - Nazarian, Saman
AU - Webster, Gregory
AU - Stojanovska, Jadranka
N1 - Publisher Copyright:
© 2024 The Authors
PY - 2024/6/1
Y1 - 2024/6/1
N2 - Cardiovascular magnetic resonance (CMR) is a proven imaging modality for informing diagnosis and prognosis, guiding therapeutic decisions, and risk stratifying surgical intervention. Patients with a cardiac implantable electronic device (CIED) would be expected to derive particular benefit from CMR given high prevalence of cardiomyopathy and arrhythmia. While several guidelines have been published over the last 16 years, it is important to recognize that both the CIED and CMR technologies, as well as our knowledge in MR safety, have evolved rapidly during that period. Given increasing utilization of CIED over the past decades, there is an unmet need to establish a consensus statement that integrates latest evidence concerning MR safety and CIED and CMR technologies. While experienced centers currently perform CMR in CIED patients, broad availability of CMR in this population is lacking, partially due to limited availability of resources for programming devices and appropriate monitoring, but also related to knowledge gaps regarding the risk-benefit ratio of CMR in this growing population. To address the knowledge gaps, this SCMR Expert Consensus Statement integrates consensus guidelines, primary data, and opinions from experts across disparate fields towards the shared goal of informing evidenced-based decision-making regarding the risk-benefit ratio of CMR for patients with CIEDs.
AB - Cardiovascular magnetic resonance (CMR) is a proven imaging modality for informing diagnosis and prognosis, guiding therapeutic decisions, and risk stratifying surgical intervention. Patients with a cardiac implantable electronic device (CIED) would be expected to derive particular benefit from CMR given high prevalence of cardiomyopathy and arrhythmia. While several guidelines have been published over the last 16 years, it is important to recognize that both the CIED and CMR technologies, as well as our knowledge in MR safety, have evolved rapidly during that period. Given increasing utilization of CIED over the past decades, there is an unmet need to establish a consensus statement that integrates latest evidence concerning MR safety and CIED and CMR technologies. While experienced centers currently perform CMR in CIED patients, broad availability of CMR in this population is lacking, partially due to limited availability of resources for programming devices and appropriate monitoring, but also related to knowledge gaps regarding the risk-benefit ratio of CMR in this growing population. To address the knowledge gaps, this SCMR Expert Consensus Statement integrates consensus guidelines, primary data, and opinions from experts across disparate fields towards the shared goal of informing evidenced-based decision-making regarding the risk-benefit ratio of CMR for patients with CIEDs.
KW - Cardiac implantable electronic device
KW - Cardiovascular magnetic resonance
KW - Guidelines
KW - MR safety
UR - http://www.scopus.com/inward/record.url?scp=85184882888&partnerID=8YFLogxK
U2 - 10.1016/j.jocmr.2024.100995
DO - 10.1016/j.jocmr.2024.100995
M3 - Article
C2 - 38219955
AN - SCOPUS:85184882888
SN - 1097-6647
VL - 26
JO - Journal of Cardiovascular Magnetic Resonance
JF - Journal of Cardiovascular Magnetic Resonance
IS - 1
M1 - 100995
ER -